Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shagufi Nazar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Archiv Der Pharmazie|April 23, 2020
Recent progress of 1,3,4-oxadiazoles as anticonvulsants: Future horizonsShagufi Nazar, Nadeem Siddiqui, Ozair Alam
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 27, 2025
EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapyShaheen Ali, Anam Ilyas, Shagufi Nazar, et al.
Chemistry & Biodiversity|April 24, 2026
Heterocyclic GABAA Receptor Modulators: Emerging Therapeutic Strategies for Epilepsy ManagementShagufi Nazar, Nadeem Siddiqui, Mukund Jha, et al.
Current Topics in Medicinal Chemistry|November 1, 2024
Triazole scaffold-based DPP-IV Inhibitors for the management of Type-II Diabetes Mellitus: Insight into Molecular Docking and SARSaniya Shamim, Ozair Alam, Mukund Jha, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 31, 2020
Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and DockingMukund Jha, Ozair Alam, Mohd Javed Naim, et al.
Bioorganic Chemistry|June 20, 2026
Identification of novel pyrazole-containing thiazolidine-2,4-dione derivatives as potent α-glucosidase inhibitors: design, synthesis and antidiabetic assessmentMukund Jha, Ozair Alam, Vishal Mathur, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Archiv Der Pharmazie|April 23, 2020
Recent progress of 1,3,4-oxadiazoles as anticonvulsants: Future horizonsShagufi Nazar, Nadeem Siddiqui, Ozair Alam
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 27, 2025
EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapyShaheen Ali, Anam Ilyas, Shagufi Nazar, et al.
Chemistry & Biodiversity|April 24, 2026
Heterocyclic GABAA Receptor Modulators: Emerging Therapeutic Strategies for Epilepsy ManagementShagufi Nazar, Nadeem Siddiqui, Mukund Jha, et al.
Current Topics in Medicinal Chemistry|November 1, 2024
Triazole scaffold-based DPP-IV Inhibitors for the management of Type-II Diabetes Mellitus: Insight into Molecular Docking and SARSaniya Shamim, Ozair Alam, Mukund Jha, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 31, 2020
Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and DockingMukund Jha, Ozair Alam, Mohd Javed Naim, et al.
Bioorganic Chemistry|June 20, 2026
Identification of novel pyrazole-containing thiazolidine-2,4-dione derivatives as potent α-glucosidase inhibitors: design, synthesis and antidiabetic assessmentMukund Jha, Ozair Alam, Vishal Mathur, et al.
Pageof 1